Alteration of Gut Microbiota Composition and Diversity in Acute and/or Chronic Graft-versus-Host Disease Following Hematopoietic Stem Cell Transplantation: A Prospective Cohort Study
- PMID: 38891979
- PMCID: PMC11171546
- DOI: 10.3390/ijms25115789
Alteration of Gut Microbiota Composition and Diversity in Acute and/or Chronic Graft-versus-Host Disease Following Hematopoietic Stem Cell Transplantation: A Prospective Cohort Study
Abstract
Changes in gut microbiome composition have been implicated in the pathogenesis of graft-versus-host disease (GvHD) after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Our objective was to explore the microbial abundance in patients with GvHD after allo-HSCT. We conducted a single-center, prospective study in patients who underwent allo-HSCT and developed grade II or higher acute GvHD and/or moderate or severe chronic GvHD, to explore the microbial abundance of taxa at the phylum, family, genus, and species level, and we utilized alpha and beta diversity indices to further describe our findings. We collected fecal specimens at -2 to +2 (T1), +11 to +17 (T2), +25 to +30 (T3), +90 (T4), and +180 (T5) days to assess changes in gut microbiota, with day 0 being the day of allo-HSCT. We included 20 allo-HSCT recipients in the study. Compared with timepoint T1, at timepoint T4 we found a significant decrease in the abundance of Proteobacteria phylum (14.22% at T1 vs. 4.07% at T4, p = 0.01) and Enterobacteriaceae family (13.3% at T1 vs. <0.05% at T4, p < 0.05), as well as a significant increase in Enterococcus species (0.1% at T1 vs. 12.8% at T4, p < 0.05) in patients who developed acute GvHD. Regarding patients who developed chronic GvHD after allo-HSCT, there was a significant reduction in the abundance of Eurobactereaceae family (1.32% at T1 vs. 0.53% at T4, p < 0.05) and Roseruria genus (3.97% at T1 vs. 0.09% at T4, p < 0.05) at T4 compared with T1. Alpha and beta diversity analyses did not reveal a difference in the abundance of bacteria at the genus level in GvHD patients at T4 compared with T1. Our study reinforces results from previous studies regarding changes in gut microbiota in patients with acute GvHD and provides new data regarding the gut microbiome changes in chronic GvHD. Future studies will need to incorporate clinical parameters in their analyses to establish their association with specific changes in gut microbiota in patients with GvHD after allo-HSCT.
Keywords: graft-versus-host disease; gut microbiota; microbial abundance; microbial diversity; stem cell transplantation.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures



Similar articles
-
Obesity induces gut microbiota alterations and augments acute graft-versus-host disease after allogeneic stem cell transplantation.Sci Transl Med. 2020 Nov 25;12(571):eaay7713. doi: 10.1126/scitranslmed.aay7713. Sci Transl Med. 2020. PMID: 33239390 Free PMC article.
-
Microbiome and diversity indices during blood stem cells transplantation - new perspectives?Cent Eur J Public Health. 2019 Dec;27(4):335-339. doi: 10.21101/cejph.a5393. Cent Eur J Public Health. 2019. PMID: 31951695
-
Dental Biofilm Microbiota Dysbiosis Is Associated With the Risk of Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation.Front Immunol. 2021 Jun 18;12:692225. doi: 10.3389/fimmu.2021.692225. eCollection 2021. Front Immunol. 2021. PMID: 34220852 Free PMC article.
-
Advancing therapeutic strategies for graft-versus-host disease by targeting gut microbiome dynamics in allogeneic hematopoietic stem cell transplantation: current evidence and future directions.Mol Med. 2025 Jan 3;31(1):2. doi: 10.1186/s10020-024-01060-x. Mol Med. 2025. PMID: 39754054 Free PMC article. Review.
-
Gut microbiota injury in allogeneic haematopoietic stem cell transplantation.Nat Rev Cancer. 2018 May;18(5):283-295. doi: 10.1038/nrc.2018.10. Epub 2018 Feb 16. Nat Rev Cancer. 2018. PMID: 29449660 Free PMC article. Review.
Cited by
-
NIH Chronic Graft-Versus-Host Disease Consensus Conference 2025 Update.Transplant Cell Ther. 2025 May 21:S2666-6367(25)01202-3. doi: 10.1016/j.jtct.2025.05.016. Online ahead of print. Transplant Cell Ther. 2025. PMID: 40409691
-
"The microbiome in graft-versus-host disease: a tale of two ecosystems".J Transl Med. 2025 Jul 25;23(1):832. doi: 10.1186/s12967-025-06797-5. J Transl Med. 2025. PMID: 40713799 Free PMC article. Review.
-
Macrophages in graft-versus-host disease (GVHD): dual roles as therapeutic tools and targets.Clin Exp Med. 2025 Mar 6;25(1):73. doi: 10.1007/s10238-025-01588-0. Clin Exp Med. 2025. PMID: 40048037 Free PMC article. Review.
References
MeSH terms
LinkOut - more resources
Full Text Sources